DHPYX | VMVAX | DHPYX / VMVAX | |
Total Expense Ratio | 0.65 | 0.07 | 929% |
Annual Report Gross Expense Ratio | 0.65 | 0.07 | 929% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | 1.678 | -0.166 | -1,011% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 3000 | 16,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 127M | 29.9B | 0% |
Annual Yield % from dividends | 1.25 | 2.31 | 54% |
Returns for 1 year | -0.18 | 6.48 | -3% |
Returns for 3 years | -0.47 | 11.23 | -4% |
Returns for 5 years | 45.19 | 56.36 | 80% |
Returns for 10 years | 63.37 | 79.79 | 79% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SBIO | 31.58 | 0.57 | +1.84% |
ALPS Medical Breakthroughs ETF | |||
FDL | 42.09 | 0.44 | +1.06% |
First Trust Morningstar Div Leaders ETF | |||
CHI | 10.23 | 0.07 | +0.69% |
Calamos Convertible Opportunities and Income Fund | |||
GLO | 5.31 | 0.01 | +0.19% |
Clough Global Opportunities Fund | |||
SNPG | 45.84 | N/A | N/A |
Xtrackers S&P 500 Growth Scrd & Scrn ETF |